RARA CRAFT DATABASE for FDA Medical Devices
510(k)K183512

FDA DEVICE FACTS

Moore Park Mask

Resmed, Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 7, 2019PRODUCT CODEBZD

Indications for use

The Moore Park mask is intended to be used by patients weighing more than 66 lb (30 kg) who have been prescribed non-invasive positive airway pressure (PAP) therapy such as CPAP or bi-level therapy. The mask is intended for single patient re-use in the home and multi-patient re-use in the hospital/institutional environment. Submission Reason: New device Similarities and differences with the predicate device: The subject and predicate device have an identical intended use and the following similarities:

• A silicone elastomer cushion to achieve an air seal at the patient’s mouth and nose

• The cushion is held in place via the mask frame

• The frame is strapped to the patient’s head and sits along the sides of the face, held in place via headgear

• An elbow assembly connects to the PAP device tubing

• Exhaust ports flush out CO2

• The mask can be disassembled for cleaning and reprocessing in accordance with the labelling

• Polymeric materials are used for the construction of the pneumatic and structural components. Foam padded fabric materials are used for the construction of the headgear. 7-May-19 Page 2-1-3

• A port compliant to ISO 5356-1 is used to connect to the PAP delivery hose

• Similar performance i.e. both masks have similar operating pressure range and pressure flow characteristics

• Same operating environments i.e. re-use in the home and hospital/institution environments The main difference between the subject Moore Park device and the previously cleared predicate Mirage Liberty Full Face Mask (K063011) is:

• The PAP device tubing is connected to the Moore Park device at the top of the patient’s head, whereas the predicate device is connected near the mouth. Non-clinical data submitted: Non-clinical verification and validation testing completed for the new device demonstrated that the Moore Park mask met all intended performance requirements. These included: Applicable performance and safety tests in accordance with ISO 17510:2015 Medical devices -- Sleep apnoea breathing therapy -- Masks and application accessories:

• CO2 rebreathing

• Pressure-Flow characteristics

• Resistance to flow

• Anti-Asphyxia valve operating pressures

• Breathing resistance Other bench tests:

• Pressure performance testing

• Mechanical Integrity of the mask system before and after the following environmental tests: o Home cleaning o Transportation and Storage o Operation environment Biocompatibility evaluation was conducted in accordance with the following standards:

• ISO 18562-1:2017 Biocompatibility evaluation of breathing gas pathways in healthcare applications -- Part 1: Evaluation and testing within a risk management process 7-May-19 Page 2-1-4

• ISO 18562-2:2017 Biocompatibility evaluation of breathing gas pathways in healthcare applications -- Part 2: Tests for emissions of particulate matter

• ISO 18562-3:2017 Biocompatibility evaluation of breathing gas pathways in healthcare applications -- Part 3: Tests for emissions of volatile organic compounds (VOCs)

• ISO 10993-1:2009 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

• ISO 10993-3:2014 Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity

• ISO 10993-5:2009 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity

• ISO 10993-10:2010 Biological evaluation of medical devices -- Part 10: Tests for irritation and skin sensitization

• ISO 10993-11:2017 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity

• ISO 10993-17:2002 Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances

• ISO 10993-18:2005 Biological evaluation of medical devices -- Part 18: Chemical characterization of materials This evaluation was conducted on components that were manufactured using new materials with patient exposure classifications of permanent external communicating device (tissue) and /or permanent skin contact. Validation of reprocessing claims included a combination of cleaning efficacy, disinfection efficacy, residual toxicity and mechanical integrity testing. Verification confirmed that the new device met the predetermined acceptance criteria and the performance is substantially equivalent to the previously cleared predicate Mirage Liberty Full Face Mask (K063011).

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026